Edwards Lifesciences Corp

GLENMEDE TRUST CO NA EW

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/17/2026

Shares

174,406

Value ($000)

14,868

Weight

0.1%

2013 Q4 - 2025 Q4 (25 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/17/2026	14,868	0.1%	174,406	12/31/2025
2025 Q1	5/15/2025	16,130	0.1%	222,551	3/31/2025
2024 Q4	2/14/2025	25,840	0.1%	349,050	12/31/2024
2024 Q3	11/13/2024	25,153	0.1%	381,168	9/30/2024
2024 Q2	8/14/2024	33,222	0.2%	359,663	6/30/2024
2024 Q1	5/15/2024	34,454	0.2%	360,546	3/31/2024
2023 Q4	2/13/2024	27,401	0.1%	359,352	12/31/2023
2023 Q3	11/14/2023	24,989	0.1%	360,690	9/30/2023
2023 Q2	8/14/2023	29,906	0.2%	361,487	6/30/2023
2023 Q1	5/15/2023	29,906	0.2%	361,487	3/31/2023
2022 Q4	2/14/2023	27,540	0.2%	369,125	12/31/2022
2022 Q3	11/16/2022	41,518	0.3%	502,476	9/30/2022
2022 Q2	8/15/2022	47,472	0.3%	499,247	6/30/2022
2022 Q1	5/16/2022	43,194	0.2%	366,931	3/31/2022
2021 Q4	2/15/2022	47,630	0.2%	367,662	12/31/2021
2021 Q3	11/15/2021	41,726	0.2%	368,581	9/30/2021
2021 Q2	8/16/2021	39,172	0.2%	378,232	6/30/2021
2021 Q1	5/18/2021	32,408	0.2%	387,476	3/31/2021
2020 Q4	2/16/2021	35,586	0.2%	390,083	12/31/2020
2020 Q3	11/16/2020	31,297	0.2%	392,102	9/30/2020
2020 Q2	8/14/2020	26,935	0.2%	389,743	6/30/2020
2020 Q1	5/20/2020	30,922	0.1%	132,555	3/31/2020
2019 Q4	2/12/2020	30,922	0.1%	132,555	12/31/2019
2014 Q1	5/7/2014	159	0.0%	2,150	3/31/2014
2013 Q4	1/31/2014	140	0.0%	2,150	12/31/2013